Polymorphism in glutathione S -transferase P1 is associated with susceptibility to chemotherapy-induced leukemia
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Glutathione S -transferases (GSTs) detoxify potentially mutagenic and toxic DNA-reactive electrophiles, including metabolites of several chemotherapeutic agents, some of which are suspected human carcinogens. Functional polymorphisms exist in at least three genes that encode GSTs, including GSTM1, GSTT1, and GSTP1. We hypothesize, therefore, that polymorphisms in genes that encode GSTs alter susceptibility to chemotherapy-induced carcinogenesis, specifically to therapy-related acute myeloid leukemia (t-AML), a devastating complication of long-term cancer survival. Elucidation of genetic determinants may help to identify individuals at increased risk of developing t-AML. To this end, we have examined 89 cases of t-AML, 420 cases of de novo AML, and 1,022 controls for polymorphisms in GSTM1, GSTT1, and GSTP1 . Gene deletion of GSTM1 or GSTT1 was not specifically associated with susceptibility to t-AML. Individuals with at least one GSTP1 codon 105 Val allele were significantly over-represented in t-AML cases compared with de novo AML cases [odds ratio (OR), 1.81; 95% confidence interval (CI), 1.11–2.94]. Moreover, relative to de novo AML, the GSTP1 codon 105 Val allele occurred more often among t-AML patients with prior exposure to chemotherapy (OR, 2.66; 95% CI, 1.39–5.09), particularly among those with prior exposure to known GSTP1 substrates (OR, 4.34; 95% CI, 1.43–13.20), and not among those t-AML patients with prior exposure to radiotherapy alone (OR,1.01; 95% CI, 0.50–2.07). These data suggest that inheritance of at least one Val allele at GSTP1 codon 105 confers a significantly increased risk of developing t-AML after cytotoxic chemotherapy, but not after radiotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical methods in cancer research. Volume I - The analysis of case-control studies.
Breslow, N. E., & Day, N. E. (1980) · PubMed · Cited by 4,988
Grimwade, D., Walker, H., Oliver, F., Wheatley, K., Harrison, C., Harrison, G., Rees, J., Hann, I., Stevens, R., Burnett, A., et al. (1998) · Blood · doi:10.1182/blood.v92.7.2322 · Cited by 2,655
Harries, L. (1997) · Carcinogenesis · doi:10.1093/carcin/18.4.641 · Cited by 737
Seidegård, J., Vorachek, W. R., Pero, R. W., & Pearson, W. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.19.7293 · Cited by 727
Ali-Osman, F., Akande, O., Antoun, G., Mao, J.-X., & Buolamwini, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.15.10004 · Cited by 713
Le Beau, M. M., Albain, K. S., Larson, R. A., Vardiman, J. W., Davis, E. M., Blough, R. R., Golomb, H. M., & Rowley, J. D. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.3.325 · Cited by 671
Watson, M. (1998) · Carcinogenesis · doi:10.1093/carcin/19.2.275 · Cited by 668
Skibola, C. F., Smith, M. T., Kane, E., Roman, E., Rollinson, S., Cartwright, R. A., & Morgan, G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12810 · Cited by 528
Self-citationLeukemia Following Hodgkin's Disease
Kaldor, J. M., Day, N. E., Clarke, E. A., Van Leeuwen, F. E., Henry-Amar, M., Fiorentino, M. V., Bell, J., Pedersen, D., Band, P., Assouline, D., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001043220102 · Cited by 485
Zimniak, P., Nanduri, B., Pikuła, S., Bandorowicz‐Pikuła, J., Singhal, S. S., Srivastava, S. K., Awasthi, S., & Awasthi, Y. C. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.00893.x · Cited by 450
Ryberg, D. (1997) · Carcinogenesis · doi:10.1093/carcin/18.7.1285 · Cited by 417
Risk of Leukemia after Platinum-Based Chemotherapy for Ovarian Cancer
Travis, L. B., Holowaty, E. J., Bergfeldt, K., Lynch, C. F., Kohler, B. A., Wiklund, T., Curtis, R. E., Hall, P., Andersson, M., Pukkala, E., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902043400504 · Cited by 359
Association of CYP 3 A 4 genotype with treatment-related leukemia
Felix, C. A., Walker, A. H., Lange, B. J., Williams, T. M., Winick, N. J., Cheung, N.-K. V., Lovett, B. D., Nowell, P. C., Blair, I. A., & Rebbeck, T. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13176 · Cited by 310
Pedersen-Bjergaard, J., Pedersen, M., Roulston, D., & Philip, P. (1995) · Blood · doi:10.1182/blood.v86.9.3542.bloodjournal8693542 · Cited by 306
Larson, R. A., Wang, Y., Banerjee, M., Wiemels, J., Hartford, C., Beau, M. M. L., & Smith, M. T. (1999) · Blood · doi:10.1182/blood.v94.2.803 · Cited by 304
Helzlsouer, K. J., Huang, H.-Y., Hoffman, S., Alberg, A. J., Comstock, G. W., Strickland, P. T., Selmin, O., Watson, M., & Bell, D. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.7.512 · Cited by 292
Reinemer, P., Dirr, H. W., Ladenstein, R., Huber, R., Lo Bello, M., Federici, G., & Parker, M. W. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90692-d · Cited by 279
Leukemia Following Chemotherapy for Ovarian Cancer
Kaldor, J. M., Day, N. E., Pettersson, F., Clarke, E. A., Pedersen, D., Mehnert, W., Bell, J., Høst, H., Prior, P., Karjalainen, S., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001043220101 · Cited by 279
Second cancers following pediatric Hodgkin's disease.
Wolden, S. L., Lamborn, K. R., Cleary, S. F., Tate, D. J., & Donaldson, S. S. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.536 · Cited by 268
Rivera, G. K., Pinkel, D., Simone, J. V., Hancock, M. L., & Crist, W. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199310283291801 · Cited by 263
Treatment-Associated Leukemia Following Testicular Cancer
Travis, L. B. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.14.1165 · Cited by 254
Identification of class-mu glutathione transferase genes GSTM1-GSTM5 on human chromosome 1p13.
Pearson, W. R., Vorachek, W. R., Xu, S. J., Berger, R., Hart, I. M., Vannais, D. B., & Patterson, D. (1993) · PubMed · Cited by 223
Fisher, B., Rockette, H., Fisher, E. R., Wickerham, D. L., Redmond, C., & Brown, A. (1985) · Journal of Clinical Oncology · doi:10.1200/jco.1985.3.12.1640 · Cited by 204
Glutathione-S-transferase pi as a determinant of drug resistance in transfectant cell lines.
Nakagawa, K., Saijo, N., Tsuchida, S., Sakai, M., Tsunokawa, Y., Yokota, J., Muramatsu, M., Sato, K., Terada, M., & Tew, K. D. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39562-6 · Cited by 197
Johansson, A.-S., Stenberg, G., Widersten, M., & Mannervik, B. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1708 · Cited by 189
Naoe, T., Takeyama, K., Yokozawa, T., Kiyoi, H., Seto, M., Uike, N., Ino, T., Utsunomiya, A., Maruta, A., Jin-nai, I., et al. (2000) · PubMed · Cited by 188
Ban, N., Takahashi, Y., Takayama, T., Kura, T., Katahira, T., Sakamaki, S., & Niitsu, Y. (1996) · PubMed · Cited by 183
Melphalan May Be a More Potent Leukemogen than Cyclophosphamide
GREENE, M. H., HARRIS, E. L., GERSHENSON, D. M., MALKASIAN, G. D., MELTON, L. J., DEMBO, A. J., BENNETT, J. M., MOLONEY, W. C., & BOICE, J. D. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-3-360 · Cited by 175
Smith, M. T., Wang, Y., Kane, E. V., Rollinson, S. J., Wiemels, J. L., Roman, E., Roddam, P. L., Cartwright, R. A., & Morgan, G. J. (2001) · Blood · doi:10.1182/blood.v97.5.1422 · Cited by 145
Self-citationHunger, S. P., Link, M. P., & Donaldson, S. S. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.10.2160 · Cited by 134
Wilson, M. H., Grant, P. J., Hardie, L. J., & Wild, C. P. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.5.791 · Cited by 125
Self-citationDiamandidou, E., Buzdar, A. U., Smith, T. L., Frye, D., Witjaksono, M. A., & Hortobágyi, G. N. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2722 · Cited by 122
Tobacco and the risk of acute leukaemia in adults
Kane, E. V., Roman, E., Cartwright, R., Parker, J. V., & Morgan, G. J. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690833 · Cited by 93
Self-citationTan, K. L., Webb, G. C., Baker, R. T., & Philip G. Board (1995) · Genomics · doi:10.1016/0888-7543(95)80037-m · Cited by 82
The p53 gene in pediatric therapy-related leukemia and myelodysplasia
Felix, C., Hosler, M. R., Provisor, D., Salhany, K., Sexsmith, E., Slater, D., Cheung, N., Winick, N., Strauss, E., Heyn, R. M., et al. (1996) · Blood · doi:10.1182/blood.v87.10.4376.bloodjournal87104376 · Cited by 80
Roddam, P. L., Rollinson, S., Kane, E. V., et al. (2000) · Pharmacogenetics · doi:10.1097/00008571-200010000-00004 · Cited by 68
Self-citationBrusamolino, E., Anselmo, A. P., Klersy, C., Santoro, M., Orlandi, E. M., PAGNUCCO, G., Lunghi, F., Maurizi-Enrici, R., Baroni, C. D., Lazzarino, M., et al. (1998) · PubMed · Cited by 66
Miyazaki, M., Kohno, K., Saburi, Y., et al. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)91016-l · Cited by 62
Genotype of glutathione S-transferase and other genetic configurations in myelodysplasia
Sasai, Y., Horiike, S., Misawa, S., Kaneko, H., Kobayashi, M., Fujii, H., Kashima, K., & Taniwaki, M. (1999) · Leukemia Research · doi:10.1016/s0145-2126(99)00119-8 · Cited by 57
Gene transfer to suppress bone marrow alkylation sensitivity
Roth, R. B., & Samson, L. D. (2000) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(00)00021-1 · Cited by 21
Cited by
Hayes, J. D., Flanagan, J. U., & Jowsey, I. R. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095857 · Cited by 3,544
Smith, S. M., Le Beau, M. M., Huo, D., Karrison, T., Sobecks, R. M., Anastasi, J., Vardiman, J. W., Rowley, J. D., & Larson, R. A. (2003) · Blood · doi:10.1182/blood-2002-11-3343 · Cited by 682
Glutathione transferases, regulators of cellular metabolism and physiology
Board, P. G., & Menon, D. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.11.019 · Cited by 446
Stoehlmacher, J. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.12.936 · Cited by 384
A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia
Di Bernardo, M. C., Crowther-Swanepoel, D., Broderick, P., Webb, E., Sellick, G., Wild, R., Sullivan, K., Vijayakrishnan, J., Wang, Y., Pittman, A. M., et al. (2008) · Nature Genetics · doi:10.1038/ng.219 · Cited by 357
Self-citation
Metadata
- Authors
- Allan, J. M., Wild, C. P., Rollinson, S., Willett, E. V., Moorman, A. V., Dovey, G. J., Roddam, P. L., Roman, E., Cartwright, R. A., & Morgan, G. J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2001-09-11
- Volume
- 98
- Issue
- 20
- Pages
- 11592-11597
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2082720294
- Cited by
- 268
- References
- 40
- FWCI
- 4.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.